Quantcast

Latest Boston Scientific Corporation Stories

2014-05-08 04:21:45

Advanced Illumina(TM) 3D Programming Software Provides Highly Significant Pain Relief in Study Patients NATICK, Mass., May 8, 2014 /PRNewswire/ -- New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra(TM) Spinal Cord Stimulator (SCS) System demonstrate the device provided sustained and highly significant relief of low-back pain six months after implantation. Results were presented at the World Institute of Pain (WIP) 7(th) World Congress in...

2014-05-06 16:33:48

Innovative Technology Designed to Treat Intrauterine Fibroids and Polyps NATICK, Mass. and CUPERTINO, Calif., May 6, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has signed a definitive agreement to acquire IoGyn, Inc., a pre-commercial stage company. The transaction is expected to close within days. IoGyn has developed and received U.S. Food and Drug Administration (FDA) clearance for the Symphion(TM) System, a next generation system for hysteroscopic...

2014-05-06 08:33:21

Global medical solutions innovator seeks to pioneer new research into effective treatments for heart failure and related cardiac conditions NATICK, Mass., May 6, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has joined Optum Labs as the Founding Medical Device Partner to help pioneer new research into effective treatments for heart failure and related cardiac conditions. Optum Labs is an open collaborative healthcare research and innovation center founded in 2013...

2014-05-01 08:37:26

Promising Clinical Data to be Presented at Annual Conference NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will present select abstracts and clinical data analyses pertaining to key issues in gastroenterology during Digestive Disease Week (DDW(®)) 2014, May 4-6 in Chicago. Data presentations will include the Boston Scientific SpyGlass((TM)) Direct Visualization System, the Resolution((TM)) Clip and the recently FDA cleared and CE marked...

2014-05-01 08:36:48

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2014 Healthcare Conference on May 13 in Las Vegas, NV. Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question and answer session regarding the company beginning at approximately 5:00 p.m. PT. A live webcast of the question and answer session will be available to interested parties via the Boston...

2014-05-01 00:21:42

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced DES system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval. "It is my great pleasure to be able to provide the Promus PREMIER(TM) Stent System to physicians and patients in Japan,"...

2014-04-29 08:34:19

Company Exceeds Earnings Per Share Guidance on the Strength of Continued Revenue Growth NATICK, Mass., April 29, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $1.774 billion during the first quarter ended March 31, 2014. This represents 4 percent operational revenue growth (constant currency basis, excluding divested businesses) and 1 percent revenue growth on a reported basis, all compared to the prior year period. The company also achieved adjusted...

2014-04-22 08:35:03

NATICK, Mass., April 22, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has conducted the first implant in the clinical trial of the next generation ACUITY(TM) X4 left-ventricular (LV) pacing leads and RELIANCE(TM) 4-FRONT defibrillation (ICD) leads. The clinical trial is designed to establish the safety and effectiveness of both lead families and is intended to support U.S. Food and Drug Administration (FDA) approval of these devices. ACUITY X4 LV leads are...

2014-04-17 08:29:03

Event Will Be Held in San Francisco, Site of the Heart Rhythm Society 35th Annual Scientific Sessions NATICK, Mass., April 17, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will host an investor event on May 8, 2014 to provide an update on company Cardiac Rhythm Management and Electrophysiology initiatives as well as developments and technologies in connection with its attendance at the 2014 Annual Heart Rhythm Society Scientific Session in San Francisco, CA. The...

2014-04-15 16:28:34

NATICK, Mass., April 15, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN(TM) MINI and INOGEN(TM) MINI ICDs, as well as the DYNAGEN(TM) X4 and INOGEN(TM) X4 CRT-Ds. The X4 line of quadripolar CRT-Ds offers 70 percent more pacing options to address high capture thresholds and phrenic nerve...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related